
Time: March 8, 2013 from 1pm to 2pm
Location: TuDiabetes homepage
Website or Map: http://www.tudiabetes.org
Event Type: live interview
Organized By: Emily Coles
Latest Activity: Mar 13
Export to Outlook or iCal (.ics)
This event has already occurred, but you can still see the recording here.
JOHN MASTROTOTARO
Vice President of Research and Development
John J. Mastrototaro, Ph.D. is Chief Technology Officer and Vice President of Research, Technology and Business Development at Medtronic Diabetes. Prior to this position, he was Vice President of Global Clinical, Scientific & Health Affairs, where he was responsible for global clinical research, clinical outcomes management, closed-loop and algorithm development initiatives, and health policy programs.
John is an internationally renowned expert in diabetes technology and has authored dozens of publications in peer reviewed journals on original clinical research and consensus reports. He is an invited guest lecturer at both domestic and international professional diabetes meetings. In 2003 John received the Bakken Award from Medtronic Inc. for his scientific & research contributions in the field of diabetes.
Prior to joining Medtronic, John was a technical project manager for Eli Lilly and Company focusing on the development of an electroenzymatic glucose sensor. He received his Masters and Ph.D degrees in Biomedical Engineering from Duke University in Durham, North Carolina. His Doctoral Dissertation was entitled “Thin-Film Multielectrode Arrays for Voltage Measurements in the Heart.” John holds 43 US patents.
John will NOT be taking questions during the event, so please post your questions for him in the comments section below by the morning of Wednesday, March 6th! Here are some examples of the kinds of questions he can answer:
Sign up to receive information from Medtronic and get a FREE copy of Naomi Kingery's new book "Sugar Free Journey".
Comment
Comment by Anna on March 8, 2013 at 1:09pm I would love to ask him what Medtronic's plan are for releasing their data/API, so that it can be integrated into platforms that analyze the data from multiple devices. It currently only allows you to link/view data from medtronic devices, which is very limiting for those of us who track multiple factors related to our disease management.
Maybe my question is " off the wall " and I am technically very unsaffy !!!
I recall reading in a Canadian paper ( National Post ???) late 2011 ( ?) about the possibility of hacking insulin pumps ...would this be a reality for the next generation of pumps ?
Comment by Sonia on March 8, 2013 at 8:11am Assuming this will be an implantable AP, will anti-rejection drugs be required? If so, what are the possible side affects? Is there any possibility of non-implant?
Comment by Tom Goffe on March 7, 2013 at 5:15pm Veo: when?
Enlite: when?
Is is necessary to live in an EU country to have access to state of the art diabetes devices?
What a great questions !! I will add another link to my FB page and a reminder to join
Comment by Santiago Jimenez on March 7, 2013 at 12:25pm Whats the realistic expectancy date for the Art. Panc. to hit the market and how expensive would it be ?
Comment by Scott Strumello on March 7, 2013 at 8:15am To what extent will dual-hormonal pumps be pursued as an option for people with hypoglycemia unawareness, and how much of a priority is that for Medtronic?
Comment by Susan B. on March 6, 2013 at 4:13pm Several questions here-What kind of customer/consumer support be provided for users of the art. pancreas? How about slender people-what adjustments will have to be made? Also will it be covered by Medicare? When will test trials on humans begin? Also when do you expect this device to become available?
Comment by Kelly Rawlings on March 6, 2013 at 2:38pm More and more people with diabetes are living longer (hooray), but going on Medicare, which doesn't cover CGMs. What does that mean for the AP, and what work is being done to achieve coverage for my friends 65 and older?
Comment by Kelly Rawlings on March 6, 2013 at 2:37pm How are developers making sensors more comfortable for kids, thin ppl (esp. w/ redundant sensors for closed loop)?
Manny Hernandez(Co-Founder, Editor, has LADA)
|
Bradford (has type 1) |
Lorraine (mother of type 1) |
Marie B (has type 1) |
|
|
|
|
|
|
This site complies with the HONcode standard for trustworthy health information: verify here.
© 2013 A community of people touched by diabetes, run by the Diabetes Hands Foundation.

RSVP for Live interview with John Mastrototaro: Road to the Artificial Pancreas to add comments!
Join Diabetes community by Diabetes Hands Foundation: TuDiabetes